238 related articles for article (PubMed ID: 17084873)
1. In vitro screening of 200 pesticides for agonistic activity via mouse peroxisome proliferator-activated receptor (PPAR)alpha and PPARgamma and quantitative analysis of in vivo induction pathway.
Takeuchi S; Matsuda T; Kobayashi S; Takahashi T; Kojima H
Toxicol Appl Pharmacol; 2006 Dec; 217(3):235-44. PubMed ID: 17084873
[TBL] [Abstract][Full Text] [Related]
2. In vitro screening for aryl hydrocarbon receptor agonistic activity in 200 pesticides using a highly sensitive reporter cell line, DR-EcoScreen cells, and in vivo mouse liver cytochrome P450-1A induction by propanil, diuron and linuron.
Takeuchi S; Iida M; Yabushita H; Matsuda T; Kojima H
Chemosphere; 2008 Dec; 74(1):155-65. PubMed ID: 18835618
[TBL] [Abstract][Full Text] [Related]
3. The transcriptional coactivator peroxisome proliferator activated receptor (PPAR)gamma coactivator-1 alpha and the nuclear receptor PPAR alpha control the expression of glycerol kinase and metabolism genes independently of PPAR gamma activation in human white adipocytes.
Mazzucotelli A; Viguerie N; Tiraby C; Annicotte JS; Mairal A; Klimcakova E; Lepin E; Delmar P; Dejean S; Tavernier G; Lefort C; Hidalgo J; Pineau T; Fajas L; Clément K; Langin D
Diabetes; 2007 Oct; 56(10):2467-75. PubMed ID: 17646210
[TBL] [Abstract][Full Text] [Related]
4. Modulation of cytochrome P-450 gene expression in endotoxemic mice is tissue specific and peroxisome proliferator-activated receptor-alpha dependent.
Barclay TB; Peters JM; Sewer MB; Ferrari L; Gonzalez FJ; Morgan ET
J Pharmacol Exp Ther; 1999 Sep; 290(3):1250-7. PubMed ID: 10454501
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of human and mouse pregnane X receptor agonistic activity in 200 pesticides using in vitro reporter gene assays.
Kojima H; Sata F; Takeuchi S; Sueyoshi T; Nagai T
Toxicology; 2011 Feb; 280(3):77-87. PubMed ID: 21115097
[TBL] [Abstract][Full Text] [Related]
6. Transgenic expression of mutant peroxisome proliferator-activated receptor gamma in liver precipitates fasting-induced steatosis but protects against high-fat diet-induced steatosis in mice.
Tanaka T; Masuzaki H; Ebihara K; Ogawa Y; Yasue S; Yukioka H; Chusho H; Miyanaga F; Miyazawa T; Fujimoto M; Kusakabe T; Kobayashi N; Hayashi T; Hosoda K; Nakao K
Metabolism; 2005 Nov; 54(11):1490-8. PubMed ID: 16253638
[TBL] [Abstract][Full Text] [Related]
7. Role of PPARalpha in mediating the effects of phthalates and metabolites in the liver.
Lapinskas PJ; Brown S; Leesnitzer LM; Blanchard S; Swanson C; Cattley RC; Corton JC
Toxicology; 2005 Feb; 207(1):149-63. PubMed ID: 15590130
[TBL] [Abstract][Full Text] [Related]
8. C333H, a novel PPARalpha/gamma dual agonist, has beneficial effects on insulin resistance and lipid metabolism.
Xu C; Wang LL; Liu HY; Zhou XB; Cao YL; Li S
Acta Pharmacol Sin; 2006 Feb; 27(2):223-8. PubMed ID: 16412273
[TBL] [Abstract][Full Text] [Related]
9. Differential responses of PPARalpha, PPARdelta, and PPARgamma reporter cell lines to selective PPAR synthetic ligands.
Seimandi M; Lemaire G; Pillon A; Perrin A; Carlavan I; Voegel JJ; Vignon F; Nicolas JC; Balaguer P
Anal Biochem; 2005 Sep; 344(1):8-15. PubMed ID: 16038868
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase-12 gene regulation by a PPAR alpha agonist in human monocyte-derived macrophages.
Souissi IJ; Billiet L; Cuaz-Pérolin C; Slimane MN; Rouis M
Exp Cell Res; 2008 Nov; 314(18):3405-14. PubMed ID: 18823978
[TBL] [Abstract][Full Text] [Related]
11. Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis.
Hays T; Rusyn I; Burns AM; Kennett MJ; Ward JM; Gonzalez FJ; Peters JM
Carcinogenesis; 2005 Jan; 26(1):219-27. PubMed ID: 15447978
[TBL] [Abstract][Full Text] [Related]
12. PAR-5359, a well-balanced PPARalpha/gamma dual agonist, exhibits equivalent antidiabetic and hypolipidemic activities in vitro and in vivo.
Kim MK; Chae YN; Son MH; Kim SH; Kim JK; Moon HS; Park CS; Bae MH; Kim E; Han T; Choi HH; Shin YA; Ahn BN; Lee CH; Lim JI; Shin CY
Eur J Pharmacol; 2008 Oct; 595(1-3):119-25. PubMed ID: 18727927
[TBL] [Abstract][Full Text] [Related]
13. Activation of mouse and human peroxisome proliferator-activated receptors (PPARs) by phthalate monoesters.
Bility MT; Thompson JT; McKee RH; David RM; Butala JH; Vanden Heuvel JP; Peters JM
Toxicol Sci; 2004 Nov; 82(1):170-82. PubMed ID: 15310864
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous, bidirectional inhibitory crosstalk between PPAR and STAT5b.
Shipley JM; Waxman DJ
Toxicol Appl Pharmacol; 2004 Sep; 199(3):275-84. PubMed ID: 15364543
[TBL] [Abstract][Full Text] [Related]
15. trans-Activation of PPARalpha and PPARgamma by structurally diverse environmental chemicals.
Maloney EK; Waxman DJ
Toxicol Appl Pharmacol; 1999 Dec; 161(2):209-18. PubMed ID: 10581215
[TBL] [Abstract][Full Text] [Related]
16. Unlike PPARgamma, PPARalpha or PPARbeta/delta activation does not promote human monocyte differentiation toward alternative macrophages.
Bouhlel MA; Brozek J; Derudas B; Zawadzki C; Jude B; Staels B; Chinetti-Gbaguidi G
Biochem Biophys Res Commun; 2009 Aug; 386(3):459-62. PubMed ID: 19527689
[TBL] [Abstract][Full Text] [Related]
17. A PPARs cross-talk concertedly commits C6 glioma cells to oligodendrocytes and induces enzymes involved in myelin synthesis.
Leisewitz AV; Urrutia CR; Martinez GR; Loyola G; Bronfman M
J Cell Physiol; 2008 Nov; 217(2):367-76. PubMed ID: 18543250
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the actions of peroxisome proliferator-activated receptor alpha on obesity by estrogen.
Jeong S; Yoon M
Obesity (Silver Spring); 2007 Jun; 15(6):1430-40. PubMed ID: 17557980
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, biological evaluation, and molecular modeling investigation of new chiral fibrates with PPARalpha and PPARgamma agonist activity.
Pinelli A; Godio C; Laghezza A; Mitro N; Fracchiolla G; Tortorella V; Lavecchia A; Novellino E; Fruchart JC; Staels B; Crestani M; Loiodice F
J Med Chem; 2005 Aug; 48(17):5509-19. PubMed ID: 16107150
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome-proliferator-activated receptor alpha agonists inhibit cyclo-oxygenase 2 and vascular endothelial growth factor transcriptional activation in human colorectal carcinoma cells via inhibition of activator protein-1.
Grau R; Punzón C; Fresno M; Iñiguez MA
Biochem J; 2006 Apr; 395(1):81-8. PubMed ID: 16343055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
